Medtronic Evolut TAVI Now Licensed for Both Bicuspid Aortic Valves at Intermediate or Greater Risk and for Low Risk of Surgical Mortality
Medtronic Evolut TAVI Now Licensed for Both Bicuspid Aortic Valves at Intermediate or Greater Risk and for Low Risk of Surgical Mortality Health Canada Issues Licence for Expanded Indications for Evolut TAVI Platform Medtronic Canada ULC, a subsidiary of Medtronic plc ― the world’s largest medical technology, services, and solutions company ― has received a new expanded indication from Health Canada for its Evolut™ Transcatheter Aortic Valve Implantation system. Medtronic’s TAVI pla...
British Columbia Nicolo Piazza Michaelj Evolut Mitch Leschuk Sam Radhakrishnan Schulich Heart Centre
Source: investingnews.com